Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
Human cytomegalovirus (HCMV) is implicated in the acceleration of a number of vascular diseases including transplant vascular sclerosis (TVS), the lesion associated with chronic rejection (CR) of solid organ transplants. Although the virus persists in the allograft throughout the course of disease, few cells are directly infected by CMV. This observation is in contrast to the global effects that CMV has on the acceleration of TVS/CR, suggesting that CMV infection indirectly promotes the vascular disease process. Recent transcriptome analysis of CMV-infected heart allografts indicates that the virus induces cytokines and growth factors associated with angiogenesis (AG) and wound healing (WH), suggesting that CMV may accelerate TVS/CR through the induction and secretion of AG/WH factors from infected cells. We analyzed virus-free supernatants from HCMV-infected cells (HCMV secretomes) for growth factors, by mass spectrometry and immunoassays, and found that the HCMV secretome contains over 1,000 cellular proteins, many of which are involved in AG/WH. Importantly, functional assays demonstrated that CMV but not herpes simplex virus secretomes not only induce AG/WH but also promote neovessel stabilization and endothelial cell survival for 2 weeks. These findings suggest that CMV acceleration of TVS occurs through virus-induced growth factors and cytokines in the CMV secretome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, the influenza A–induced secretome (120) exhibited significant overlap with those of HSV-1 (121) and HCMV (124) in cytokines, cathepsin proteases, and danger-associated signals, suggesting the activation of common downstream signaling pathways in response to different viruses.”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [124]
Experimental — accuracy not yet measuredIn the citing paper
“Pathway analysis revealed that the HCMV-specific secretome was enriched for proangiogenic and wound healing factors.”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [124]
In the citing paper
“Indeed, supernatants from HCMV-infected cells induced angiogenesis and wound healing responses in primary human endothelial cells.”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“peptides from the most recent version of the IPI human database (8).”
BackgroundA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 1×
“software was used to remove redundant protein identifications (26).”
MethodAngiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276 · cited 2×
“Breakdown of the tightly regulated angiogenic balance contributes to a variety of pathological disorders, including cancer and autoimmune and cardiovascular diseases (4).”
BackgroundRegulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629 · cited 2×
“AG is an important component of WH, involving inflammation (46), tissue formation, and remodeling, whereby a local milieu created by the coordinated action of growth factors, cytokines, enzymes, extracellular matrix (ECM) components, and inflammatory cells interacts with the injured tissue, the result of which is the…”
Background(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Cytomegalovirus Infection Is Associated With Cardiac Allograft Rejection and Atherosclerosis
Grattan, M. T. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420240075030 · Cited by 968 · cited 1×
“TVS represents the hallmark of CR in vascularized solid organ transplants, and HCMV infection nearly doubles the 5-year rate of cardiac graft failure due to accelerated TVS (11).”
BackgroundBurgoyne, R. D., & Morgan, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00031.2002 · Cited by 934
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753 · cited 1×
“Numerous epidemiological and animal studies link human cytomegalovirus (HCMV) to the acceleration of vascular diseases including arterial restenosis, atherosclerosis, and transplant vascular sclerosis (TVS) (23, 24, 37).”
BackgroundFundamental Concepts of the Angiogenic Process
Folkman, J. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479465 · Cited by 666 · cited 2×
“A number of proteins that mediate integrin signaling pathways were also present in the HCMV secretome, such as laminins, widely distributed ECM proteins involved in cell adhesion signaling (10).”
BackgroundElectrical wound-healing assay for cells in vitro
Keese, C. R., Wegener, J., Walker, S. R., & Giaever, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307588100 · Cited by 421 · cited 1×
“To quantify the ability of the HCMV secretome to accelerate WH, we used automated electric cell substrate impedance-sensing technology to electrically wound cell monolayers and measure wound healing in real time (5, 15).”
MethodA Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation
Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261803 · Cited by 376 · cited 1×
“In heart transplant recipients, ganciclovir, a potent inhibitor of CMV replication, delays the time to allograft rejection (25, 44).”
BackgroundComparison of three in vitro human ‘angiogenesis’ assays with capillaries formed in vivo
Donovan, D., Brown, N. J., Bishop, E. T., & Lewis, C. E. (2001) · Angiogenesis · doi:10.1023/a:1012218401036 · Cited by 342 · cited 2×
“To determine if the abundance of AG factors in the HCMV, but not the mock-infected secretome, stimulated efficient angiogenesis, we employed a modification of a standard in vitro angiogenesis assay in which the HCMV or mock-infected secretome was the sole source of AG factors (7).”
BackgroundMethodCYTOMEGALOVIRUS ANTIGEN WITHIN HUMAN ARTERIAL SMOOTH MUSCLE CELLS
MELNICK, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92529-1 · Cited by 331 · cited 1×
“Numerous epidemiological and animal studies link human cytomegalovirus (HCMV) to the acceleration of vascular diseases including arterial restenosis, atherosclerosis, and transplant vascular sclerosis (TVS) (23, 24, 37).”
BackgroundQian, W.-J., Liu, T., Monroe, M. E., Strittmatter, E. F., Jacobs, J. M., Kangas, L. J., Petritis, K., Camp, D. G., & Smith, R. D. (2005) · Journal of Proteome Research · doi:10.1021/pr0498638 · Cited by 317 · cited 1×
“higher levels for proteins identified with multiple peptides (32).”
BackgroundSelf-citationValantine, H. A., Gao, S.-Z., Menon, S. G., Renlund, D. G., Hunt, S. A., Oyer, P., Stinson, E. B., Brown, B. W., Merigan, T. C., & Schroeder, J. S. (1999) · Circulation · doi:10.1161/01.cir.100.1.61 · Cited by 292 · cited 2×
“This parallels observations for human heart transplant recipients, where ganciclovir prolongs graft survival in the presence of CMV infection (44).”
BackgroundPlaque Assay of Cytomegalovirus Strains of Human Origin
Wentworth, B. B., & French, L. (1970) · Experimental Biology and Medicine · doi:10.3181/00379727-135-35031 · Cited by 279 · cited 8×
“Subsequently, NHDF were infected with HCMV, UV-inactivated HCMV, or HSV-1 at a multiplicity of infection (MOI) of 3 in SFM or mock infected for 3 h at 37°C. Cells were washed three times with SFM and incubated for an additional 48 h. Supernatants were centrifuged (10,000 g, 15 min), followed by two high-speed centrifu…”
MethodInfluentialHistopathology of graft coronary disease.
Billingham, M. E. (1992) · PubMed · Cited by 249
Cardiac allograft vasculopathy: current concepts, recent developments, and future directions.
Hosenpud, J. D., Shipley, G. D., & Wagner, C. R. (1992) · PubMed · Cited by 218
Cytokines and growth factors in atherogenesis.
Clinton, S. K., & Libby, P. (1992) · PubMed · Cited by 199
A review on pro- and anti-angiogenic factors as targets of clinical intervention
BOUIS, D., KUSUMANTO, Y., MEIJER, C., MULDER, N., & HOSPERS, G. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2005.10.006 · Cited by 165 · cited 2×
“Activated inflammatory cells and SMC within and near vascular lesions are important local sources of proangiogenic factors (2).”
BackgroundLemström, K. B., Bruning, J. H., Bruggeman, C. A., Lautenschlager, I. T., & Häyry, P. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116622 · Cited by 149 · cited 1×
“The role of HCMV in TVS/CR development is clear; however, the mechanisms involved in this process remain illusive for the following reasons: HCMV disease etiology is multifactorial; HCMV is ubiquitous throughout the human population; HCMV infection is lifelong and infects all of the cell types involved in TVS, includi…”
BackgroundLibby, P., Salomon, R., Payne, D. D., Schöen, F. J., & Pober, J. S. (1989) · PubMed · Cited by 141
Choroidal neovascularization: a wound healing perspective.
Kent, D. L., & Sheridan, C. (2003) · PubMed · Cited by 138
Lemström, K., Koskinen, P., Krogerus, L., Daemen, M., Bruggeman, C., & Häyry, P. (1995) · Circulation · doi:10.1161/01.cir.92.9.2594 · Cited by 108 · cited 1×
“The role of HCMV in TVS/CR development is clear; however, the mechanisms involved in this process remain illusive for the following reasons: HCMV disease etiology is multifactorial; HCMV is ubiquitous throughout the human population; HCMV infection is lifelong and infects all of the cell types involved in TVS, includi…”
BackgroundKhurana, R., & Simons, M. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00259-1 · Cited by 106 · cited 2×
“A growing body of evidence supports a role for angiogenesis (AG) and wound healing (WH) in the development of vascular diseases (17, 34).”
BackgroundDemonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.
Wu, T. ‐., Hruban, R. H., Ambinder, R. F., Pizzorno, M. C., Cameron, D. E., Baumgartner, W. A., Reitz, B. A., Hayward, G. S., & Hutchins, G. M. (1992) · PubMed Central · Cited by 98
Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent
Oyabu, J., Ueda, Y., Ogasawara, N., Okada, K., Hirayama, A., & Kodama, K. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.07.025 · Cited by 92 · cited 1×
“Not surprisingly, antifibrotic/antiangiogenic agents like rapamycin decrease neointimal hyperplasia in coronary artery stents (31, 40, 41).”
BackgroundThuesen, L., Kelbæk, H., Kløvgaard, L., Helqvist, S., Jørgensen, E. O., Aljabbari, S., Krusell, L. R., Jensen, G. V. H., Bøtker, H. E., Saunamäki, K. I., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.06.035 · Cited by 90 · cited 1×
“Not surprisingly, antifibrotic/antiangiogenic agents like rapamycin decrease neointimal hyperplasia in coronary artery stents (31, 40, 41).”
BackgroundStreblow, D. N., Kreklywich, C. N., Yin, Q., Melena, V. T. D. L., Corless, C. L., Smith, P. A., Brakebill, C., Cook, J. W., Vink, C., Bruggeman, C. A., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2182-2194.2003 · Cited by 86 · cited 3×
“Importantly, the effects of RCMV on TVS acceleration are not organ type specific but occur in various solid organs (29, 35, 38, 43).”
BackgroundSelf-citationNoda, S., Aguirre, S. A., Bitmansour, A., Brown, J. M., Sparer, T. E., Huang, J., & Mocarski, E. S. (2006) · Blood · doi:10.1182/blood-2005-05-1833 · Cited by 81
Lemström, K., & Koskinen, P. (1997) · Circulation · doi:10.1161/01.cir.96.4.1240 · Cited by 77
ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers
Charrier, L., Yan, Y., Driss, A., Laboisse, C. L., Sitaraman, S. V., & Merlin, D. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00262.2004 · Cited by 56 · cited 1×
“To quantify the ability of the HCMV secretome to accelerate WH, we used automated electric cell substrate impedance-sensing technology to electrically wound cell monolayers and measure wound healing in real time (5, 15).”
MethodShibata, M., Suzuki, H., Nakatani, M., Koba, S., Geshi, E., Katagiri, T., & Takeyama, Y. (2001) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0336-4 · Cited by 55 · cited 2×
“Increased adventitial neovascularization is also seen at sites of neointimal hyperplasia following arterial or venous stenting (34).”
BackgroundStreblow, D. N., Kreklywich, C. N., Andoh, T. F., Moses, A. V., Dumortier, J. R. J.-P. B., Smith, P. P., DeFilippis, V. R., Früh, K., Nelson, J. A., & Orloff, S. L. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02062.x · Cited by 51 · cited 10×
“This analysis provides the first glimpse into the complexity of the HCMV secretome and reveals that HCMV infection increases the release of a number of crucial WH/AG factors.”
BackgroundResultInfluentialSelf-citationOrloff, S. L., Streblow, D. N., Söderberg‐Nauclér, C., Yin, Q., Kreklywich, C. N., Corless, C. L., Smith, P. A., Loomis, C. B., Mills, L. K., Cook, J. W., et al. (2002) · Transplantation · doi:10.1097/00007890-200203150-00005 · Cited by 42 · cited 2×
“Importantly, the effects of RCMV on TVS acceleration are not organ type specific but occur in various solid organs (29, 35, 38, 43).”
BackgroundSelf-citationTikkanen, J., Kallio, E. A., Bruggeman, C. A., KOSKINEN, P. K., & Lemström, K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2008058 · Cited by 42 · cited 1×
“Importantly, the effects of RCMV on TVS acceleration are not organ type specific but occur in various solid organs (29, 35, 38, 43).”
BackgroundBRUNING, J. H., Persoons, M. C. J., Lemström, K., Stals, F. S., Clercq, E. D., Bruggeman, C. A., BRUNING, J. H., Persoons, M. C. J., Stals, F. S., & Bruggeman, C. A. (1994) · Transplant International · doi:10.1111/j.1432-2277.1994.tb01393.x · Cited by 38
Orloff, S. L., Yin, Q., Corless, C. L., Orloff, M. S., Rabkin, J. M., & Wagner, C. R. (2000) · Transplantation · doi:10.1097/00007890-200004150-00015 · Cited by 33 · cited 1×
“The role of HCMV in TVS/CR development is clear; however, the mechanisms involved in this process remain illusive for the following reasons: HCMV disease etiology is multifactorial; HCMV is ubiquitous throughout the human population; HCMV infection is lifelong and infects all of the cell types involved in TVS, includi…”
BackgroundSelf-citationMechanistic Study of Malononitrileamide FK778 in Cardiac Transplantation and CMV Infection in Rats
Zeng, H., Waldman, W. J., Yin, D., Knight, D. A., Shen, J., Ma, L., Meister, G. T., Chong, A. S., & Williams, J. W. (2004) · Transplantation · doi:10.1097/01.tp.0000137334.46155.94 · Cited by 31 · cited 1×
“Similar to the clinical scenario, antiviral therapy reduces the acceleration of rejection, underscoring the need for viral replication (42, 48).”
Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus
Reinhardt, B., Schaarschmidt, P., Bossert, A. S., Lüske, A., Finkenzeller, G., Mertens, T., & Michel, D. (2004) · Journal of General Virology · doi:10.1099/vir.0.80327-0 · Cited by 27 · cited 1×
“Previously, others have shown that HCMV infection of EC increases the expression of FGF and PDGF-BB, both of which are potent stimuli in SMC proliferation (13, 14, 20, 33 ).”
BackgroundFitzgerald, J. T., Gallay, B. J., Taranto, S. E., McVicar, J. P., Troppmann, C., Chen, X., McIntosh, M. J., & Perez, R. V. (2004) · Transplantation · doi:10.1097/01.tp.0000122184.97674.20 · Cited by 24 · cited 1×
“In kidney transplant patients, the presence of HCMV infection, whether asymptomatic or displaying overt symptoms, negatively impacts allograft survival (9).”
BackgroundInkinen, K. A., Lahesmaa, R., Brandt, A. M., Katajamaa, M., Halme, L., Höckerstedt, K., & Lautenschlager, I. T. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2004.12.015 · Cited by 21
Success Rate of Implantation and Mid-Term Outcomes of the Sirolimus-Eluting Stent
Suzuki, S., Kamihata, H., Hata, T., Hayashi, F., Miura, A., Yoshinaga, M., Karakawa, M., & Kitaura, Y. (2006) · Circulation Journal · doi:10.1253/circj.71.15 · Cited by 19 · cited 1×
“Not surprisingly, antifibrotic/antiangiogenic agents like rapamycin decrease neointimal hyperplasia in coronary artery stents (31, 40, 41).”
BackgroundSparer, T. E., Gosling, J., Schall, T. J., & Mocarski, E. S. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2004.24.611 · Cited by 17 · cited 1×
“Importantly, CMV carries chemokine homologues that also recruit and stimulate a multitude of host cellular infiltrates that mediate the inflammatory response (27, 36).”
BackgroundSoule, J. L., Streblow, D. N., Andoh, T. F., Kreklywich, C. N., & Orloff, S. L. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.187 · Cited by 17 · cited 2×
“Importantly, the effects of RCMV on TVS acceleration are not organ type specific but occur in various solid organs (29, 35, 38, 43).”
BackgroundSelf-citationInkinen, K. A., Holma, K., Soots, A. P., Krogerus, L. A., Loginov, R. J., Bruggeman, C. A., Ahonen, J., & Lautenschlager, I. T. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00078-2 · Cited by 12
Orloff, S. L. (1999) · Journal of Clinical Virology · doi:10.1016/s1386-6532(99)90486-9 · Cited by 12
Self-citationTikkanen, J., Kallio, E.-L., Pulkkinen, V., Bruggeman, C. A., Koskinen, P., & Lemström, K. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)02686-5 · Cited by 7
Research works printed but not linked: 1
- Melnick, J. L., E. Adam, and M. E. DeBakey. 1998. The link between CMV and atherosclerosis. Infect. Med. 15479-486. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Infect.%20Med.&volume=15&publication_year=1998&pages=479&)]
Cited by
Li, S., Zhu, J., Zhang, W., Chen, Y., Zhang, K., Popescu, L. M., Ma, X., Bond Lau, W., Rong, R., Yu, X., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.012237 · Cited by 333
The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions
Michaelis, M., Doerr, H. W., & Cinatl, J. (2009) · Neoplasia · doi:10.1593/neo.81178 · Cited by 293
“[65] Dumortier J, Streblow DN, Moses AV, Jacobs JM, Kreklywich CN, Camp D,”
BackgroundTargeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation
Yan, D., Ng, W. L., Zhang, X., Wang, P., Zhang, Z., Mo, Y.-Y., Mao, H., Hao, C., Olson, J. J., Curran, W. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011397 · Cited by 227
HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6–STAT3 Axis
Slinger, E., Maussang, D., Schreiber, A., Siderius, M., Rahbar, A., Fraile-Ramos, A., Lira, S. A., Söderberg-Nauclér, C., & Smit, M. J. (2010) · Science Signaling · doi:10.1126/scisignal.2001180 · Cited by 224
“B. A. Stout, M. E. Bates, L. Y. Liu, N. N. Farrington, P. J. Bertics, IL-5 and granulocytemacrophage colony-stimulating factor activate STAT3 andSTAT5 and promotePim-1 and cyclin D3 protein expression in human eosinophils.”
BackgroundCytomegalovirus-induced immunopathology and its clinical consequences
Varani, S., & Landini, M. (2011) · Herpesviridae · doi:10.1186/2042-4280-2-6 · Cited by 206
“Activated inflammatory cells, fibroblasts, and SMCs within vascular lesions are important local sources of factors that promote angiogenesis [179], which accelerates the development of transplant vascular sclerosis (Figure 1C).”
BackgroundResult
Metadata
- Authors
- Dumortier, J., Streblow, D. N., Moses, A. V., Jacobs, J. M., Kreklywich, C. N., Camp, D., Smith, R. D., Orloff, S. L., & Nelson, J. A.
- Affiliations
- Vaccine and Gene Therapy Institute, Oregon Health Sciences University, Portland, Oregon
- Oregon Health & Science University (US)
- Pacific Northwest National Laboratory (US)
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2008-07
- Volume
- 82
- Issue
- 13
- Pages
- 6524-6535
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC2447085
- OpenAlex
- W2124238701
- Cited by
- 123
- References
- 50
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 10 · 2020: 6 · 2019: 6 · 2018: 2 · 2017: 4 · 2016: 7 · 2015: 5 · 2014: 12 · 2013: 12 · 2012: 7
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- American Heart Association
- National Institutes of Health (RR 00163, AI21640)
- National Heart, Lung, and Blood Institute (HL 66238-01, R01HL083194, R01HL071695, HL 083194, R01HL065754, HL65754, R01HL085451, HL71695, R01HL066238, R01HL088603)
- National Institute of Allergy and Infectious Diseases (AI21640, R37AI021640, R01AI021640)
- National Center for Research Resources (P51RR000163, K01RR000163, RR-00163.)
- Topics
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human cytomegalovirus, angiogenesis, wound healing, chronic rejection, cardiac allograft, growth factors, cytokines, endothelial cell survival, herpes simplex virus, vascular disease
- MeSH terms
- Cell Line, Centrifugation, Cytomegalovirus, Fibroblasts, Humans, Immunoassay, Bodily Secretions, Mass Spectrometry, Wound Healing, Cytokines, Angiogenesis Inducing Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.